Effects of α- And β-adrenergic stimulation on free magnesium concentrations in platelets from healthy and obese individuals

Magnesium Research

Volumn 14, Issue 4, 2001, Pages 263-272

  Malara, Alba ^a   Corsonello, Andrea ^a,b   Buemi, Michele ^a   De Domenico, Donatella ^a   Ientile, Riccardo ^a   Corica, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b INRCA   (Italy)

Author keywords

Adrenergic system; Clonidine; Free magnesium; Isoproterenol; Obesity; Platelets

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; INSULIN; ISOPRENALINE; MAGNESIUM; NORADRENALIN; YOHIMBINE;

ADULT; ARTICLE; BLOOD; DRUG EFFECT; HUMAN; MALE; METABOLISM; OBESITY; THROMBOCYTE; TIME;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ADULT; BLOOD PLATELETS; CLONIDINE; EPINEPHRINE; HUMANS; INSULIN; ISOPROTERENOL; MAGNESIUM; MALE; NOREPINEPHRINE; OBESITY; TIME FACTORS; YOHIMBINE;

EID: 0035753064     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Flatman, P.W. (1984) Magnesium transport across cell membranes. J. Membr. Biol. 80, 1-14.
2. Paolisso, G., Scheen, A., D'Onofrio, F. & Lefebvre, P. (1990) Magnesium and glucose homeostasis. Diabetologia 33, 511-514.
3. Flatman, P.W. (1991) Mechanisms of magnesium transport. Annu. Rev. Physiol. 53, 259-271.
4. Hwang, D.L., Yen, C.F. & Nadler, J.L. (1993) Insulin increases intracellular magnesium transport in human platelets. J. Clin. Endocrinol. Metab. 76, 549-553.
5. Takaya, J., Higashino, H., Miyazaki Kobayashi, Y. (1998) Effects of Insulin and insulin-like growth factor-1 on intracellular magnesium of platelets. Exp. Mol. Pathol. 65, 104-109.
6. Yoshimura, M., Oshima, T., Matsuura, H., Watanabe, M., Higashi, Y., Ono, N., Hiraga, H., Kambe, M. & Kajiyama, G. (1995) Effect of the transmembrane gradient of magnesium and sodium on the regulation of cytosolic free magnesium concentration In human platelets. Clin. Sci. 89, 293-298.
7. Corica, F., Allegra, A., Ientile, R., Buerni, M., Corsonello, A., Bonanzinga, S., Macaione, S. & Ceruso, D. (1999) Changes in plasma, crythrocyte and platelet magnesium levels in normotensive and hypertensive obese subjects during oral glucose tolerance test. Am. J. Hypertens. 12, 128-136.
8. 2) as a measure of fatness. Int. J. Obes. 15, 295-302.
9. WHO (1988): Measuring obesity - classification and description of anthropometric data. Copenhagen: WHO Regional Office for Europe. Nutrition Unit. # EUR/ICP/NUT 125, 1988.
10. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
11. Raju, B., Murphy, E., Levy, L.A., Hall, R.D. & London, R.E. (1989) A fluorescent indicator for measuring cytosolic free magnesium. Am. J. Physiol. 256, C540-C5448.
12. Altura, B.M. & Altura, B.T. (1985) New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. I. Clinical aspects. Magnesium 4, 226-244.
13. Iseri, L.T., Freed, J. & Bures, A.R. (1975) Magnesium deficiency and cardiac disorders. Am. J. Med. 58, 837-46.
14. Nadler, J., Malayan, S., Luong, H., Shaw, S., Natarajan, R. & Rude, R. (1992) Evidence that intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care 15, 835-841.
15. Resnick, L.M., Gupta, R.K., Gruenspan, H., Alderman, M.H. & Laragh, J.H. (1991) Cellular ions in hypertension, diabetes, and obesity. Hypertension 17, 951-957.
16. Corica, F., Corsonello, A., Buemi, M., De Gregorio, T., Malara, A., Nicita Mauro, V., Macalone, S. & Ientile, R. (1999) Platelet magnesium depletion in normotensive and hypertensive obese subjects: the role of salt-regulating hormones and catecholamines. Magnes. Res. 12, 287-296.
17. Zemva, A. & Zemva, Z. (2000) Ventricular ectopic activity, left ventricular mass, hyperinsulinemia, and intracellular magnesium in normotensive patients with obesity. Angiology 51, 101-106.
18. De Leeuw, I., Vansant, G. & Van Gaal, L. (1992) Magnesium and obesity: influence of gender, glucose tolerance, and body fat distribution on circulating magnesium concentrations. Magnes. Res. 5, 183-187.
19. Paolisso, G. & Barbagallo, M. (1997) Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am. J. Hypertens. 10, 346-55.
20. Anfossi, G. & Trovati, M. (1996) Role of catecholamines In platelet function: pathophysiological and clinical significance. Eur. J. Clin. Invest. 26, 353-370.
21. Motulsky, H.J., Shattil, S.J. & Insel. P.A. (1980) Characterization of alpha;2-adrenergic receptors on human platelets using [3H]yohimbine. Biochem. Biophys. Res. Commun. 97. 1562-1570.
22. Shattil, S.J., McDonough. M., Turnbull, J. & Insel, P.A. (1981) Characterization of alpha;-adrenergic receptors in human platelets using [3H]clonidine. Mol. Pharmacol. 19, 179-183.
23. Mooney, J.J., Horne, W.C., Handin, R.I., Schildkraut, J.J. & Alexander, R.W. (1982) Sodium inhibits both adenylate cyclase and high affinity 3H-labeled p-aminoclonidine binding to α2-adrenergic receptors in purified human platelet membranes. Mol. Pharmacol. 21. 600-608.
24. Strasser, R.H., Ihl-Vahl. R. & Marquetant, R. (1992) Molecular biology of adrenergic receptors. J. Hypertens. 10, 501-506.
25. Neubig, R.R., Gantzos, R.D. & Thomsen, W.J. (1988) Mechanism of agonist and antagonist binding to α2-adrenergic receptors: evidence for a precoupled receptor-guanine nucleotide protein complex. Biochemistry 27, 2374-2384
26. Michell, R.H. (1985) Inositol lipid breakdown as a step in α-adrenergic stimulus-response coupling. Clin. Sci. 68 (suppl. 10). 43s-46s.
27. Erne, P., Resink, T.J., Bolli, P., Hefti. A., Ritz, R. & Buhler, F.R. (1984): Free calcium response to adrenaline in platelets of normal and hypertensive (untreated and treated) subjects. J. Hypertens. 2 (S3). 159-161.
28. Kaibuchi, K., Takai, Y., Ogawa, Y., Kimura, S. & Nishizuka, Y. (1982) Inhibitory action of adenosine 3′-5′-monophosphate on phosphatidylinositol turnover: difference in tissue response. Biochem. Biophys. Res. Comm. 104, 105-112.
29. Watson, S.P., McConnell, R.T. & Lapetina, E.G. (1984) The rapid formation of inositol phosphates in human platelets by thrombin is inhibited by prostacyclin. J. Biol. Chem. 259, 13199-13203.
30. Pannocchia, A. & Hardisty, R.M. (1985) Cyclic AMP inhibits platelet activation independently of its effect on cytosolic free calcium. Biochem. Biophys. Res. Comm. 127, 339-345.
31. 2+ concentration in isolated rat hearts via αadrenergic and muscarinic receptors. J. Mol. Cell. Cardiol. 30, 2307-18.
32. Nishimura, H., Matsubara, T., Ikoma, Y., Nakayama, S. & Sakamoto, N. (1993) Effects of prolonged application of isoprenaline on intracellular free magnesium concentration in isolated heart of rat. Br. J. Pharmacol. 109, 443-448.
33. Durlach, J. & Bara, M. (2000) Le Magnésium en biologie et en médecine. EM inter, achan-Franre, pp. 26-28.
34. 2+ extrusion by alphal-and beta-adrenergic agonists in rat liver cells. Am. J. Physiol. Gastrointest. Liver. Physiol. 279, G943-G950.
35. 2+ levels in human erythrocytes. Biochim. Biophys. Acta. 1220, 31-36.
36. 2+ in rat ventricular myocytes studied with fluorescent indicator furaptra. Jpn. J. Physiol. 44, 357-378.
37. 31P NMR study. Can. J. Physiol. Pharmacol. 75, 1015-1021.
38. 2+ uptake in mouse convoluted tubule cells. Am. J. Physiol. Renal. Physiol. 279. F1116-F1123.
39. Takaya, J., Higashino, H. & Kobayashi. Y. (2000) Can magnesium act as a second messenger? Current data on translocation induced by various biologically active substances. Magnes. Res. 13, 139-146.
40. Weidmann, P., Courten, M., Bohler, L.M. & Shore, F. (1993) The pathogenesis of hypertension and obese subjects. Drugs 46, 197-209.
41. Troisi, R.J., Weiss, S.T., Parker, D.R., Sparrow, D., Young, J.B. & Landsberg, L. (1991) Relation of obesity and diet to sympathetic nervous system activity. Hypertension 17, 669-677.
42. Sundaresan, P.R., Weintraub, M., Hershey, L.A., Kroening, B.H., Hasday, J.D. & Banerjee, S.P. (1983) Platelet alpha-adrenergic receptors in obesity: alteration with weight loss. Clin. Pharmacol. Ther. 33, 776-785.